Envoy Medical COCH Foreign currency translation gains (losses)
Foreign currency translation gains (losses) at other companies
Other financials
Where this comes from
Reported directly by Envoy Medical in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax.
The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Envoy Medical's foreign currency translation gains (losses).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Envoy Medical's foreign currency translation gains (losses)?
- Envoy Medical (COCH) reported foreign currency translation gains (losses) of -$1K in Q1 2026.
- How has Envoy Medical's foreign currency translation gains (losses) changed year-over-year?
- Envoy Medical's foreign currency translation gains (losses) decreased by 116.7% year-over-year, from $6K to -$1K.
- What does foreign currency translation gains (losses) mean?
- Measures the gains or losses arising from the translation of financial statements from a foreign functional currency into the reporting currency. These adjustments are driven by fluctuations in exchange rates and are recorded in equity rather than net income. It provides transparency into the impact of global operations on the company's overall financial position.